SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 131 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $84,000 | +33.3% | 6,435 | +11.9% | 0.00% | – |
| Q1 2016 | $63,000 | +53.7% | 5,751 | +28.9% | 0.00% | – |
| Q4 2015 | $41,000 | +2.5% | 4,461 | -23.0% | 0.00% | – |
| Q3 2015 | $40,000 | +135.3% | 5,792 | +225.6% | 0.00% | – |
| Q2 2015 | $17,000 | +41.7% | 1,779 | +28.4% | 0.00% | – |
| Q1 2015 | $12,000 | 0.0% | 1,385 | -0.4% | 0.00% | – |
| Q4 2014 | $12,000 | 0.0% | 1,390 | -16.9% | 0.00% | – |
| Q3 2014 | $12,000 | +33.3% | 1,672 | -2.8% | 0.00% | – |
| Q2 2014 | $9,000 | +12.5% | 1,720 | 0.0% | 0.00% | – |
| Q1 2014 | $8,000 | -11.1% | 1,720 | -0.2% | 0.00% | – |
| Q4 2013 | $9,000 | -70.0% | 1,723 | -70.6% | 0.00% | – |
| Q3 2013 | $30,000 | +87.5% | 5,859 | +83.2% | 0.00% | – |
| Q2 2013 | $16,000 | – | 3,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |